Dr Forbes Manson gained his PhD at the University of Aberdeen (1990) before completing post-doctoral positions at the University of Edinburgh (1989-1995). Dr Manson then moved into the field of human genetics when he joined the laboratory of Professor Alan Wright (MRC Human Genetics Unit, Edinburgh) in 1995. There Dr Manson was part of the team that first published RPGR as the gene mutated in X-linked retinitis pigmentosa RP3 and he went on to make a conditional knockout mouse model for Rpgr and was the first to discover the protein’s centriolar localisation. In 2002 Dr Manson moved to The University of Manchester where he is a senior lecturer in ophthalmology. Dr Manson established and was Director of the MSc Genomic Medicine programmes until 2019 and am now the Faculty Director of International PGR. Research interests include correcting the function of mutant proteins associated with human disease using small molecules, and epigenetic modification of gene expression to correct pathogenic mutations.
Dr Forbes Manson gained his PhD at the University of Aberdeen (1990) before completing post-doctoral positions at the University of Edinburgh (1989-1995). Dr Manson then moved into the field of human genetics when he joined the laboratory of Professor Alan Wright (MRC Human Genetics Unit, Edinburgh) in 1995. There Dr Manson was part of the team that first published RPGR as the gene mutated in X-linked retinitis pigmentosa RP3 and he went on to make a conditional knockout mouse model for Rpgr and was the first to discover the protein’s centriolar localisation. In 2002 Dr Manson moved to The University of Manchester where he is a senior lecturer in ophthalmology. Dr Manson established and was Director of the MSc Genomic Medicine programmes until 2019 and am now the Faculty Director of International PGR. Research interests include correcting the function of mutant proteins associated with human disease using small molecules, and epigenetic modification of gene expression to correct pathogenic mutations.